Cargando…

Recent Advances in Drug Therapy for Parkinson's Disease

Parkinson's disease (PD) is a neurodegenerative disease manifesting with motor and non-motor symptoms. Current treatment mainly relies on medication as a symptomatic therapy modulating neurotransmitters. Dopamine replacement therapy has been established, and levodopa is the gold standard for tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Hidetomo, Shiraishi, Tomotaka, Umehara, Tadashi, Omoto, Shusaku, Iguchi, Yasuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876715/ https://www.ncbi.nlm.nih.gov/pubmed/35110492 http://dx.doi.org/10.2169/internalmedicine.8940-21

Ejemplares similares

Mini Review: Correlations of Cognitive Domains With Cerebrospinal Fluid α-Synuclein Levels in Patients With Parkinson's Disease
por: Murakami, Hidetomo, et al.
Publicado: (2021)

Diagnostic Yield of Early Examination for Venous Thrombosis in Patients with Cryptogenic Stroke and a Right-to-left Shunt
por: Shiraishi, Tomotaka, et al.
Publicado: (2020)

Hyperadrenergic Orthostatic Hypotension With Pure Peripheral Sympathetic Denervation Associated With Sjogren’s Syndrome
por: Takahashi, Junichiro, et al.
Publicado: (2021)

Thrombotic Microangiopathy Presenting with Intestinal Involvement Following Long-term Interferon-β1b Treatment for Multiple Sclerosis
por: Omoto, Shusaku, et al.
Publicado: (2017)

Recent advances in treating Parkinson’s disease
por: Oertel, Wolfgang H.
Publicado: (2017)

Recent advances in understanding and treatment of Parkinson’s disease
por: Tarakad, Arjun, et al.
Publicado: (2020)

Recent advances in the assessment and treatment of falls in Parkinson's disease
por: Snijders, Anke H, et al.
Publicado: (2010)

Recent imaging advances in the diagnosis and management of Parkinson’s disease
por: Brooks, David J, et al.
Publicado: (2009)

Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
por: Mao, Qi, et al.
Publicado: (2020)

Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
por: Shao, Yaping, et al.
Publicado: (2019)

Recent Advances in Drug Delivery System Fabricated by Microfluidics for Disease Therapy
por: Jia, Fuhao, et al.
Publicado: (2022)

Recent Advances in Biomarkers for Parkinson’s Disease
por: He, Runcheng, et al.
Publicado: (2018)

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

Nanosponges for Drug Delivery and Cancer Therapy: Recent Advances
por: Iravani, Siavash, et al.
Publicado: (2022)

The Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement
por: Zhang, Hanwen, et al.
Publicado: (2022)

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
por: Koppula, Sushruta, et al.
Publicado: (2012)

Recent advances in rehabilitation for Parkinson’s Disease with Exergames: A Systematic Review
por: Garcia-Agundez, Augusto, et al.
Publicado: (2019)

Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
por: Cavallieri, Francesco, et al.
Publicado: (2023)

Drug therapy in patients with Parkinson’s disease
por: Müller, Thomas
Publicado: (2012)

Endoscopic Diagnosis of Eosinophilic Esophagitis: Basics and Recent Advances
por: Abe, Yasuhiko, et al.
Publicado: (2022)

Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Symptoms
por: Sivanandy, Palanisamy, et al.
Publicado: (2021)

Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy
por: Kim, Hyosuk, et al.
Publicado: (2021)

Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
por: Murakami, Hidetomo, et al.
Publicado: (2019)

Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023)

Mechanisms of Autoimmune Cell in DA Neuron Apoptosis of Parkinson's Disease: Recent Advancement
por: Zheng, Zijian, et al.
Publicado: (2022)

Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease
por: Zhang, Yunlong, et al.
Publicado: (2016)

Advances in Parkinson’s Disease Drugs
por: Di Stefano, Antonio, et al.
Publicado: (2021)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

Recent Developments in Parkinson's Disease
por: Tsai, Diane C.
Publicado: (1986)

Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies
por: Abusrair, Ali H., et al.
Publicado: (2022)

Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy
por: Xu, Jiangsheng, et al.
Publicado: (2022)

Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
por: Stanchina, Michele, et al.
Publicado: (2020)

Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements
por: Yao, Longping, et al.
Publicado: (2021)

Recent developments in the treatment of Parkinson's Disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson’s disease and de novo dementia with Lewy bodies
por: Oka, Hisayoshi, et al.
Publicado: (2020)

Recent Advances in Biocatalysis for Drug Synthesis
por: Kinner, Alina, et al.
Publicado: (2022)

Recent advances in phenotypic drug discovery
por: Swinney, David C., et al.
Publicado: (2020)

Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023)

Recent advances in migraine therapy
por: Antonaci, Fabio, et al.
Publicado: (2016)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_he6ocnttlm95qkbg6b4aatjocf